Cote d'Ivoire vs Panama: Antiretroviral therapy coverage for PMTCT
Cote d'Ivoire
88.0%
in 2024
Panama
86.0%
in 2024
Cote d'Ivoire rank
31st
Panama rank
34th
Antiretroviral therapy coverage for PMTCT over time
- Cote d'Ivoire
- Panama
How they compare
Cote d'Ivoire currently reports 88.0% against 86.0% in Panama, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Panama ahead.
Cote d'Ivoire ranks 31st and Panama ranks 34th of 84 countries.
Across the 3 decades both report, Cote d'Ivoire averaged higher in 1 and Panama in 2.
Head to head by decade
| Decade | Cote d'Ivoire | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 41.4% | 28.4% | Panama |
| 2010s | 75.3% | 77.7% | 2.4% | Panama |
| 2020s | 90.6% | 85.0% | 5.6% | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Cote d'Ivoire or Panama?
- Cote d'Ivoire, at 88.0% against 86.0% in Panama as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Cote d'Ivoire and Panama?
- 2.0%, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and Panama?
- 25 years are reported by both, from 2000 to 2024.
- How do Cote d'Ivoire and Panama rank globally for antiretroviral therapy coverage for pmtct?
- Cote d'Ivoire ranks 31st and Panama ranks 34th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).